Evogene Ltd. (EVGN)
NASDAQ: EVGN · Real-Time Price · USD
1.270
+0.300 (30.93%)
At close: Apr 21, 2025, 4:00 PM
1.160
-0.110 (-8.66%)
After-hours: Apr 21, 2025, 7:36 PM EDT
Evogene Employees
Evogene had 117 employees as of December 31, 2024. The number of employees decreased by 25 or -17.61% compared to the previous year.
Employees
117
Change (1Y)
-25
Growth (1Y)
-17.61%
Revenue / Employee
$72,744
Profits / Employee
-$140,897
Market Cap
7.42M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
EVGN News
- 17 hours ago - ICL to Acquire the Activity of Evogene's Subsidiary, Lavie Bio - PRNewsWire
- 6 weeks ago - Evogene Ltd. (EVGN) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Evogene Reports Fourth Quarter and Full Year 2024 Financial Results - PRNewsWire
- 6 weeks ago - Evogene Announces the Appointment of Nir Nimrodi as the New Chairperson of the Board, Effective March 5, 2025 - PRNewsWire
- 2 months ago - Evogene Schedules Fourth Quarter 2024 Financial Results Release - PRNewsWire
- 2 months ago - AgPlenus Announces Discovery of a New Mode of Action for Fungicides Against Wheat Disease - PRNewsWire
- 5 months ago - Evogene Ltd. (EVGN) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Evogene Reports Third Quarter 2024 Financial Results - PRNewsWire